PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
49.82%
G&A change of 49.82% while CRON.TO maintains overhead. Bruce Berkowitz would investigate efficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
49.82%
Operating expenses change of 49.82% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
49.82%
Total costs change of 49.82% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
9.15%
Interest expense change of 9.15% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
No Data
No Data available this quarter, please select a different quarter.
-49.81%
EBITDA decline while CRON.TO shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-49.81%
Operating income decline while CRON.TO shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
9.15%
Other expenses change of 9.15% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
-52.65%
Pre-tax income decline while CRON.TO shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.65%
Net income decline while CRON.TO shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-52.63%
EPS decline while CRON.TO shows 0.00% growth. Joel Greenblatt would examine position.
-52.63%
Diluted EPS decline while CRON.TO shows 0.00% growth. Joel Greenblatt would examine position.
-0.38%
Share count reduction while CRON.TO shows 0.00% change. Joel Greenblatt would examine strategy.
-0.38%
Diluted share reduction while CRON.TO shows 0.00% change. Joel Greenblatt would examine strategy.